HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

XX Testicular Disorders of Sex Development 46

Subscribe to New Research on XX Testicular Disorders of Sex Development 46

Congenital conditions in individuals in which male GONADS develop in a genetic female (female to male sex reversal).

Also Known As:

46, XX Testicular Disorders of Sex Development; 46, XX Gonadal Sex Reversal; 46, XX Testicular DSD; Gonadal Sex Reversal, 46, XX; Sex Reversal, Gonadal, 46, XX

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	XY Disorders of Sex Development 46 (Male Pseudohermaphroditism)
2.	XX Disorders of Sex Development 46 (Female Pseudohermaphroditism)
3.	Ovotesticular Disorders of Sex Development
4.	Gonadal Dysgenesis (Gonadal Agenesis)

Experts

1.	Nishio, Hidenori: 1 article (08/2014)
2.	Kojima, Yoshiyuki: 1 article (08/2014)
3.	Kamisawa, Hideyuki: 1 article (08/2014)
4.	Moritoki, Yoshinobu: 1 article (08/2014)
5.	Mizuno, Kentaro: 1 article (08/2014)
6.	Hayashi, Yutaro: 1 article (08/2014)
7.	Kohri, Kenjiro: 1 article (08/2014)
8.	Nakane, Akihiro: 1 article (08/2014)
9.	Kurokawa, Satoshi: 1 article (08/2014)
10.	Guercio, Gabriela: 1 article (01/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to XX Testicular Disorders of Sex Development 46:

1.	Testosterone (Sustanon)FDA Link 01/01/2014 - "In this article, we review the current evidence of the fertility potential of patients with: (1) dysgenetic DSD, including pure and partial gonadal dysgenesis, asymmetric gonadal differentiation, ovotesticular DSD and 46,XX testicular DSD; (2) 46,XY DSD due to abnormal testicular hormone production or action, including testosterone production deficiencies, dihydrotestosterone deficiency, androgen insensitivity and defects in anti-Müllerian hormone or its receptor, and (3) 46,XX DSD due to excessive androgen exposure in individuals with no testicular tissue, i.e. "
2.	Dihydrotestosterone (Androstanolone)IBA 01/01/2014 - "In this article, we review the current evidence of the fertility potential of patients with: (1) dysgenetic DSD, including pure and partial gonadal dysgenesis, asymmetric gonadal differentiation, ovotesticular DSD and 46,XX testicular DSD; (2) 46,XY DSD due to abnormal testicular hormone production or action, including testosterone production deficiencies, dihydrotestosterone deficiency, androgen insensitivity and defects in anti-Müllerian hormone or its receptor, and (3) 46,XX DSD due to excessive androgen exposure in individuals with no testicular tissue, i.e. "
3.	HormonesIBA 01/01/2014 - "In this article, we review the current evidence of the fertility potential of patients with: (1) dysgenetic DSD, including pure and partial gonadal dysgenesis, asymmetric gonadal differentiation, ovotesticular DSD and 46,XX testicular DSD; (2) 46,XY DSD due to abnormal testicular hormone production or action, including testosterone production deficiencies, dihydrotestosterone deficiency, androgen insensitivity and defects in anti-Müllerian hormone or its receptor, and (3) 46,XX DSD due to excessive androgen exposure in individuals with no testicular tissue, i.e. "
4.	DNA (Deoxyribonucleic Acid)IBA 08/01/2014 - "Whole genomic DNA was extracted from the peripheral blood of 4 patients with 46,XX testicular disorders of sex development who were SRY negative. " 08/01/2014 - "Elucidation of distinctive genomic DNA structures in patients with 46,XX testicular disorders of sex development using genome wide analyses."